NK Cell Lymphoma: Clinical Trials

1 trial for NK Cell Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Not yet recruiting 1
Phase 21Not yet recruiting 1

Follow NK Cell Lymphoma: new trials by email Literature Review of NK Cell Lymphoma trials Research Report on NK Cell Lymphoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies
CD7-specific CAR gene-engineered T cells - T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma
Phase 1 / Phase 2Not yet recruitingShenzhen Geno-Immune Medical Institute302026-12-312026-11-02

Narrower conditions

Leukemia, Myeloid, Acute (1)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia (1)  ·  Leukemia, Lymphoid (1)  ·  Leukemia, Myeloid (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Sponsors

Shenzhen Geno-Immune Medical Institute (1)

Countries

China (1)